Flinders University researchers were part of an international team that conducted a scoping review that identified 2,441 records and found that just 32 studies examined how cancer patients, survivors and caregivers feel about generative AI being used in their care. The study is published in the European Journal of Cancer.
Cancer Patients Urged to Influence Generative AI Development in Oncology
An international team, including researchers from Flinders University, conducted a review revealing that only 32 studies focused on cancer patients' perspectives regarding the use of generative AI in their care. This highlights a significant gap in understanding patient needs in oncology. For Iran, this underscores the importance of incorporating patient voices in healthcare technology discussions.
👥 Key Players
📰 What Happened
An international research team, including Flinders University, found that only 32 studies have explored cancer patients' views on generative AI in their treatment. This indicates a significant gap in understanding how these technologies can be tailored to meet patient needs.
- The review identified 2,441 records but only 32 studies focused on patient perspectives.
- This gap suggests that patient input is not adequately considered in the development of generative AI technologies in oncology.
💡 Why It Matters
📚 Background
Generative AI has the potential to transform oncology by personalizing treatment, but its development must consider patient needs and experiences to be effective.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%